Popularity of Ozempic and Wegovy among privately insured patients may worsen disparities, suggests study
byUniversity of Southern CaliforniaCredit: Pixabay/CC0 Public DomainA USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity
Updated on: August 08,2024
0

Popularity of Ozempic and Wegovy among privately insured patients may worsen disparities, suggests study
byUniversity of Southern CaliforniaCredit: Pixabay/CC0 Public DomainA USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity
Updated on:August 08,2024
0
